Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Birmingham, Alabama 35294


Purpose:

The purpose is to test the safety and effectiveness of intravenous ribavirin therapy in persons with suspected and subsequently proven hantavirus infection. The hantavirus is spread through the air into the lungs when dry rodent feces are moved or disturbed. It is characterized by fever and bleeding.


Study summary:

Patients are randomized to receive either ribavirin or a placebo for 7 days. At the completion of therapy, patients will be seen on follow-up visits on days 14, 28, and 84.


Criteria:

Inclusion Criteria: You may be eligible for this study if you: - Are 12 years of age or older. - Are not pregnant. - Agree to practice sexual abstinence or use accepted barrier methods of birth control/contraception. - Are not breast-feeding. - Have a positive blood test for hantavirus. - Have symptoms suggestive of hantavirus illness. Exclusion Criteria: You will not be eligible for this study if you: - Have severe low blood count (anemia). - Have a diagnosis of other respiratory viruses (influenza, RSV, etc.). - Have group A Streptococcus with symptoms of streptococcal pharyngitis, a positive culture from a normally sterile site, or symptoms of bacterial pneumonia. - Are HIV positive. - Have cancer. - Have had any period of irregular heartbeat. - Have had chemotherapy or other drugs that suppress the immune system within 30 days. - Have taken by mouth or injection any antiviral drug (other than acyclovir, famciclovir, amantadine or rimantadine.) - Have taken by mouth or injection corticosteroids equivalent to approximately 0.5 mg/kg prednisone. - Have taken any experimental drug within 30 days prior to enrollment.


NCT ID:

NCT00001123


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Birmingham, Alabama 35294
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.